| Identification | Back Directory | [Name]
Methanone, (2-oxido-1,2,5-oxadiazole-3,4-diyl)bis[(2-methoxyphenyl)- (9CI) | [CAS]
886536-76-1 | [Synonyms]
Methanone, (2-oxido-1,2,5-oxadiazole-3,4-diyl)bis[(2-methoxyphenyl)- (9CI) | [Molecular Formula]
C18H14N2O6 | [MOL File]
886536-76-1.mol | [Molecular Weight]
354.31 |
| Chemical Properties | Back Directory | [Boiling point ]
591.6±60.0 °C(Predicted) | [density ]
1.35±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
-4.16±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
NCGC00351170 is an antiplatelet agent that disrupts the calcium and integrin-binding protein 1 (CIB1)-αIIbβ3 interaction. NCGC00351170 inhibits thrombin-induced human platelet aggregation[1]. | [References]
[1] Golla K, et al. Small-Molecule Disruptors of the Interaction between Calcium-and Integrin-Binding Protein 1 and Integrin αIIbβ3 as Novel Antiplatelet Agents[J]. ACS Pharmacology & Translational Science, 2024. |
|
|